Market cap
$511.4B
Price as of
2026-10-29
Latest filing
8-K · 2026-09-22
Alerts
8
Price$159.18 +5.36% 3M daily closessample
160.88144.33
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 27INS
- Oct 19INS
- Oct 08INS
- Oct 01INS
- Sep 22SEC
- Sep 17INS
- Sep 10INS
- Sep 01INS
Company facts
SEC EDGAR registration- Name
- Helus Pharma Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- -5sample, -100 to +100
- Reporting currency
- USD
Who is positioning in HELP
sample- Insiders
- 16 insider transactions over 90 days, net selling, $336.2M
- Congress
- 4 members traded over 90 days
- Institutions · 13F
- 14 funds hold $7.9B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$22.2B +11.3% y/y
Q4 2024Q3 2026
Inventory$13.9B +10.4% y/y
Q4 2024Q3 2026
Accounts receivable$10.4B +14.6% y/y
Q4 2024Q3 2026
Total debt$28.3B +17.6% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $481.3B +0.7% 3M
- Sample peer B
- $438.3B +13.7% 3M
- Sample peer C
- $297.6B -10.6% 3M
- Sample peer D
- $153.8B +15.5% 3M
- Sample peer E
- $145.9B +10.0% 3M